Immunotactoid glomerulopathy

**What is the long-term prognosis for immunotactoid glomerulopathy?**

The long-term prognosis for immunotactoid glomerulopathy is difficult to predict due to the rarity of the condition, but some studies suggest that 50% of patients will have end-stage kidney disease (ESKD) by 5 years after diagnosis. Patients with ESKD may either pursue dialysis or kidney transplantation. The disease may recur in the transplanted kidney. However, the degree and rate of recurrence remains unclear due to the rarity of this disease. Researchers believe the rate of progression of the disease in the transplanted kidney is slower than in the native kidney. The rate of recurrence seems to be higher in patients who have monoclonal gammopathy.

Last updated on 05-01-20

Immunotactoid Glomerulopathy UNC Health Care Kidney Center. Reference Link Fervenza F, Sethi S, Appel G. Glomerular diseases due to nonamyloid fibrillar deposits UpToDate. July 16, 2014; Reference Link

Connect with other users with Immunotactoid glomerulopathy on the RareGuru app

Do you have information about a disease, disorder, or syndrome? Want to suggest a symptom?
Please send suggestions to RareGuru!

The RareGuru disease database is regularly updated using data generously provided by GARD, the United States Genetic and Rare Disease Information Center.

People Using the App

Join the RareGuru Community

To connect, share, empower and heal today.

People Using the App